Abeona Therapeutics Inc. (ABEO) financial statements (2021 and earlier)

Company profile

Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
NEW YORK, NY 10019
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:9512985138694012
Cash and cash equivalents1312919138694012
Short-term investments82 66    
Other undisclosed cash, cash equivalents, and short-term investments(0) 0    
Receivables  00000
Other undisclosed current assets334300 
Total current assets:9813289141694112
Noncurrent Assets
Operating lease, right-of-use asset78
Property, plant and equipment111391100
Intangible assets, net (including goodwill)3469763641395
Goodwill323232323232 
Intangible assets, net (excluding goodwill)236434875
Other undisclosed noncurrent assets1110000
Total noncurrent assets:5391863842395
TOTAL ASSETS:1512231741791118017
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities89102412
Accounts payable5462412
Accrued liabilities364    
Deferred revenue00
Debt02    0
Due to related parties3227     
Deferred revenue and credits3111
Other undisclosed current liabilities2 10 4  
Total current liabilities:4239206813
Noncurrent Liabilities
Long-term debt and lease obligation76     
Long-term debt, excluding current maturities1      
Operating lease, liability56
Liabilities, other than long-term debt   3475
Deferred revenue and credits3445
Business combination, contingent consideration, liability     3 
Other undisclosed noncurrent liabilities(5) 20  44
Total noncurrent liabilities:762034119
Total liabilities:4945409121212
Stockholders' equity
Stockholders' equity attributable to parent10317813417099685
Common stock1100000
Additional paid in capital672664544529431378301
Accumulated other comprehensive loss(0)      
Accumulated deficit(571)(486)(410)(360)(332)(311)(296)
Total stockholders' equity:10317813417099685
TOTAL LIABILITIES AND EQUITY:1512231741791118017

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues10 31111
Revenue, net1111
Cost of revenue  (1)(1)(1)(1)(1)
Cost of goods and services sold      (1)
Gross profit:10 2001(0)
Operating expenses(91)(77)(60)(28)(24)(19)(4)
Other undisclosed operating income      1
Operating loss:(81)(77)(58)(28)(24)(19)(3)
Nonoperating income (expense)  2124(24)
Investment income, nonoperating  21240
Interest and debt expense(4)(0)   (0)(1)
Net loss:(86)(77)(57)(27)(22)(15)(27)
Other undisclosed net income (loss) attributable to parent11(0)  01
Net loss attributable to parent:(84)(76)(57)(27)(22)(15)(27)
Preferred stock dividends and other adjustments      (3)
Net loss available to common stockholders, diluted:(84)(76)(57)(27)(22)(15)(30)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(86)(77)(57)(27)(22)(15)(27)
Comprehensive loss:(86)(77)(57)(27)(22)(15)(27)
Other undisclosed comprehensive income, net of tax, attributable to parent1      
Comprehensive loss, net of tax, attributable to parent:(84)(77)(57)(27)(22)(15)(27)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: